674 related articles for article (PubMed ID: 20617750)
1. [Axial spondyloarthritis and ankylosing spondylitis].
Nordström D; Kauppi M
Duodecim; 2010; 126(12):1467-74. PubMed ID: 20617750
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of ankylosing spondylitis and undifferentiated spondyloarthritis with TNF alpha-antagonists].
Brandt J; Sieper J; Braun J
Z Rheumatol; 2003 Jun; 62(3):218-27. PubMed ID: 12827397
[TBL] [Abstract][Full Text] [Related]
3. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.
van der Heijde D; Sieper J; Maksymowych WP; Dougados M; Burgos-Vargas R; Landewé R; Rudwaleit M; Braun J;
Ann Rheum Dis; 2011 Jun; 70(6):905-8. PubMed ID: 21540200
[TBL] [Abstract][Full Text] [Related]
4. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
5. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
[TBL] [Abstract][Full Text] [Related]
6. The classification and diagnostic criteria of ankylosing spondylitis.
Raychaudhuri SP; Deodhar A
J Autoimmun; 2014; 48-49():128-33. PubMed ID: 24534717
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
[TBL] [Abstract][Full Text] [Related]
8. Early spondyloarthritis.
Poddubnyy D; Rudwaleit M
Rheum Dis Clin North Am; 2012 May; 38(2):387-403. PubMed ID: 22819091
[TBL] [Abstract][Full Text] [Related]
9. Editorial review: how early should ankylosing spondylitis be treated with a tumor necrosis factor-blocker?
Haibel H; Sieper J
Curr Opin Rheumatol; 2010 Jul; 22(4):388-92. PubMed ID: 20473176
[TBL] [Abstract][Full Text] [Related]
10. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
Deodhar A; Strand V; Kay J; Braun J
Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
Rudwaleit M; Baraliakos X; Listing J; Brandt J; Sieper J; Braun J
Ann Rheum Dis; 2005 Sep; 64(9):1305-10. PubMed ID: 15778243
[TBL] [Abstract][Full Text] [Related]
12. Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial.
Song IH; Weiß A; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Lange E; Freundlich B; Rudwaleit M; Sieper J
Ann Rheum Dis; 2013 Jun; 72(6):823-5. PubMed ID: 23172749
[TBL] [Abstract][Full Text] [Related]
13. Advances in classification, basic mechanisms and clinical science in ankylosing spondylitis and axial spondyloarthritis.
Robinson PC; Benham H
Intern Med J; 2015 Feb; 45(2):127-33. PubMed ID: 25132517
[TBL] [Abstract][Full Text] [Related]
14. Biological therapies in the spondyloarthritides--the current state.
Braun J; Sieper J
Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
[TBL] [Abstract][Full Text] [Related]
15. [Early diagnosis of ankylosing spondylitis].
Pavelka K
Vnitr Lek; 2006; 52(7-8):726-9. PubMed ID: 16967615
[TBL] [Abstract][Full Text] [Related]
16. Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.
Maksymowych WP; Inman RD; Gladman D; Thomson G; Stone M; Karsh J; Russell AS;
J Rheumatol; 2003 Jun; 30(6):1356-63. PubMed ID: 12784417
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study on clinical characteristics of Saudi axial spondylarthritis: preliminary results.
Bedaiwi MK; AlRasheed RF; Bin Zuair A; Alqurtas EM; Baeshen MO; Omair MA
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5241-5247. PubMed ID: 34486699
[TBL] [Abstract][Full Text] [Related]
18. [Imaging in inflammatory spine diseases].
Theumann N; Aubry-Rozier B; Guntern D
Rev Med Suisse; 2009 Mar; 5(194):566, 568-70. PubMed ID: 19405271
[TBL] [Abstract][Full Text] [Related]
19. Current therapeutics for spondyloarthritis.
Toussirot É
Expert Opin Pharmacother; 2011 Nov; 12(16):2469-77. PubMed ID: 21988214
[TBL] [Abstract][Full Text] [Related]
20. How early should ankylosing spondylitis be treated with tumour necrosis factor blockers?
Sieper J; Rudwaleit M
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv61-4. PubMed ID: 16239391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
